Newell Brands Inc.: the Board of Directors (the “Board”) of Newell Brands Inc. (the “Company”) voted to increase the

Newell Brands Inc. filed a Form 8-K on Monday, 9 November 2026: On November 4, 2026, the Board of Directors (the “Board”) of Newell Brands Inc. (the

Published on by

Newell Brands Inc. filed a Form 8-K at 13:35 UTC on Monday, 9 November 2026. On November 4, 2026, the Board of Directors (the “Board”) of Newell Brands Inc. (the “Company”) voted to increase the size of the Board from eight members to nine and to elect William Newlands to the Board, effective January 1, 2027.

There are no arrangements or understandings pursuant to which he was selected as a director and no transactions reportable under Item 404(a) of Regulation S-K. Mr. Newlands will receive the same compensation as the Company’s other non-employee directors, as described in the Company’s Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on March 26, 2026.

Form 8-K is the current report that U.S. public companies file with the SEC to disclose significant events between their regular reports. This filing reports Item 5.02 (Departure or Election of Directors or Certain Officers) and Item 9.01 (Financial Statements and Exhibits). The press release is attached as Exhibit 99.1.

Source: U.S. Securities and Exchange Commission (EDGAR) filing

More on this Story & Related In-Depth Reports

Markets & Finance

Fervo Energy Co reports third-quarter 2026 Ended Q3 2026 with unrestricted cash and cash equivalents of $1.9 billion

Fervo Energy Company, global pioneer of next-generation geothermal energy, today reported financial and operational resu...

Markets & Finance

Sonoco Products Company: Chief Executive Officer Transition On November 6, 2026, R. Howard Coker, Director, President

Sonoco Products Company filed a Form 8-K at 13:38 UTC on Monday, 9 November 2026....

Markets & Finance

Whitehawk Therapeutics, Inc. (the " Company ") issued a press release announcing its financial results for the quarter

Whitehawk Therapeutics, Inc. filed a Form 8-K at 13:04 UTC on Monday, 9 November 2026....

Markets & Finance

Spruce Biosciences, Inc. (the “Company”) issued a press release announcing its financial results for the third quarter

Spruce Biosciences, Inc. filed a Form 8-K at 13:05 UTC on Monday, 9 November 2026....